Back to Search
Start Over
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
- Source :
- Plus Company Updates. June 29, 2024
- Publication Year :
- 2024
-
Abstract
- SAN FRANCISCO: GT Biopharma, Inc. has issued the following news release: GT Biopharma, Inc. (the 'Company') (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.799636746